4//SEC Filing
RABBANI ELAZAR 4
Accession 0000930413-19-000105
CIK 0000316253other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 4:31 PM ET
Size
7.2 KB
Accession
0000930413-19-000105
Insider Transaction Report
Form 4
RABBANI ELAZAR
DirectorChairman and CEO
Transactions
- Exercise/Conversion
Common Stock
2019-01-14$2.70/sh+2,782$7,511→ 1,661,003 total - Exercise/Conversion
Stock Option (to acquire common stock)
2019-01-14−41,634→ 180,615 totalExercise: $2.70Exp: 2019-01-17→ Common Stock (41,634 underlying)
Footnotes (2)
- [F1]Represents an exercise of options to acquire 41,634 shares, which, after the company withheld the exercise price for such options and the applicable taxes, resulted in a delivery of 2,782 shares to Dr. Rabbani.
- [F2]Includes (i) 5,308 shares held in the name of Dr. Rabbani as custodian for certain of his children, and of which Dr. Rabbani disclaims beneficial ownership, (ii) 18,794 shares held in the name of Dr. Rabbani's wife as custodian for certain of their children, and of which Dr. Rabbani disclaims beneficial ownership and (iii) 33,550 shares held in the company's 401(k) plan.
Documents
Issuer
ENZO BIOCHEM INC
CIK 0000316253
Entity typeother
Related Parties
1- filerCIK 0000903568
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 4:31 PM ET
- Size
- 7.2 KB